Proximie, a London (United Kingdom) based Medtech startup, announced on 21st April 2021 that it has raised US$ 38 million in its series B funding round. The round was led by F-Prime Capital along with participation from Global Ventures, Maverick Ventures, Questa Capital Management, Eight Roads Ventures and more.
Investors: F-Prime Capital is a Massachusetts, United States, based venture capital firm that was founded in 1946. It is an early to late stage investor that mainly invests in healthcare and technology companies. It currently has over 200 portfolio companies and US$ 2 billion in assets under management. Its portfolio includes companies such as Acacia Pharma, BioPalette, Blackduck, Alibaba and more.
“Proximie is poised to become a clear global leader in digitising surgery, with the platform’s value increasing as each new user and operating room joins the network. Nadine’s vision, informed by her ongoing work as a surgeon, has attracted and guided a stellar team with the potential to create one of the most connected, efficient, and impactful digital surgery networks in the world.”—Jon Lim, partner at F-Prime Capital.
Purpose of investment: The funds from the current round would be utilised by Proximie to support its expansion across the US and Europe. Further, investments would also be directed towards new technology implementations and R&D.
About Proximie:
Proximie was founded in the year 2016 by Nadine Hachach-Haram. It essentially leverages its AI and augmented reality technologies to enable clinicians to collaborate and share the best clinical practices remotely.
There is constant innovation in every field today. Proximie enables remote teams of doctors to virtually interact in a way that mimics real-time in-person collaborations. It means, in the case of surgery, doctors can show where to make an incision or the technique used in real-time.
In the last 12 months, Proximie has witnessed exceptional growth with over 10,000 surgical interactions including around 300 hospitals and 40 countries.
What the CEO has to say:
“We are delighted to be working with this distinguished group of new investors and are thrilled by the continued support from our existing shareholders. This investment will fuel our growth and gives our platform the opportunity to revolutionise an important area of unmet need in the healthcare sector. We aim to have a profound impact on surgeons and the patients they treat through connected surgical care, making care more efficient, effective, affordable and accessible.”—Nadine Hachach-Haram, CEO and Founder of Proximie.
For more extensive analysis and Market Intelligence reports feel free to approach us or visit our website: Venture Capital Market Intelligence Reports | VCBay.
We try our best to fact check and bring the best, well-researched and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback and thank you for stopping by!
Next article
 based Medtech startup, announced on 21st April 2021 that it has raised US$ 38 million in its series B funding round. The round was led by F-Prime Capital along with participation from Global Ventures, Maverick Ventures, Questa Capital Management, Eight Roads Ventures and more.){kind=link}